MedTrace Logo

Dietary Intake of Whole Walnuts in Adult Subjects Under Low Cardiovascular Risk

NCT03227497 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2017-07-24

No results posted yet for this study

Summary

This cross-over study investigates health effects of dietary intake of whole walnuts towards cardiovascular risk factors in adults under low cardiovascular risk.

Investigators hypothesize that daily intake of whole nuts as a replacement meal, would improve cardiovascular risk factors, including traditional risk factors and molecular biomarkers.

The participants are randomly assigned to receive either study treatment, or no treatment, and are crossed after five weeks.

The study subjects are instructed to continue with their habitual diet and physical activity.

Conditions

  • Cardiovascular Risk Factor
  • Metabolic Syndrome
  • Hypertension

Interventions

DIETARY_SUPPLEMENT

Whole Walnuts

Intervention arm includes whole walnuts taken as dietary replacement meal during the day, and between breakfast and lunch, and/or lunch and dinner. Importantly, none of the main meals, including breakfast, lunch and dinner are to be replaced by study intervention, and the study subjects are instructed to do so. Walnuts are provided with the same producer at the Belgrade market.

Sponsors & Collaborators

  • Centre of Research Excellence in Nutrition and Metabolism

    collaborator UNKNOWN

  • University of Belgrade

    lead OTHER

Principal Investigators

  • Maria Glibetic, Prof · Center of Research Excellence in Nutrition and Metabolism, Institute for Medical Resaerch

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-21
Primary Completion
2017-07-15
Completion
2017-07-15

Countries

  • Serbia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03227497 on ClinicalTrials.gov